Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way. The Executive Medical Director, Medical Strategy (hepatologist), is a key member of the Medical Affairs global team and serves as Madrigal’s clinical and medical expert in Metabolic Dysfunction–Associated Steatohepatitis (MASH). This hepatology/liver expert will bring deep clinical and industry expertise to guide strategic direction and serve as a trusted advisor across the organization. In this role, the Exec Med Dir will partner closely with teams across Medical Affairs—including both field and headquarters functions in the U.S. and globally—to ensure scientific and medical alignment. The individual will also collaborate extensively with Clinical Development, Regulatory Affairs, Commercial, and Market Access to support cross-functional decision-making and integrated execution. Working in close partnership with the Vice President, Global Medical Affairs Strategy, the Exec Med Dir will help inform and help shape the company’s medical strategy for resmetirom and future assets. As a core member of the Medical Product Team (MPT), the Exec Med Dir will contribute to critical product and portfolio decisions that inform the strategic direction of Madrigal’s medical and scientific initiatives. The position will report to VP, Global Medical Affairs Strategy and is hybrid from the Conshohocken, PA or Waltham, MA offices (3 days a week in person). All incumbents are responsible for following applicable Division & Madrigal policies and procedures.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
501-1,000 employees